Literature DB >> 10218695

Autosomal dominant Stargardt-like macular dystrophy: I. Clinical characterization, longitudinal follow-up, and evidence for a common ancestry in families linked to chromosome 6q14.

A O Edwards1, A Miedziak, T Vrabec, J Verhoeven, T S Acott, R G Weleber, L A Donoso.   

Abstract

PURPOSE: Characterize the phenotype of autosomal dominant Stargardt-like macular dystrophy in two families linked to chromosome 6q14 and determine whether they share a common ancestry.
METHODS: Two families spanning 10 generations were identified and studied independently. Participating members were examined and genetic linkage and genotyping performed.
RESULTS: Presenting symptoms included decreased vision, hemeralopia, and mild photophobia. The subjective onset of visual loss ranged from age 3 to 50 with a mean of 14 years. A Snellen acuity of 20/200 occurred at a mean age of 22 years. Over decades, the macular lesion enlarged and visual acuity decreased to 20/300 to 20/800. The typical phenotype was well-circumscribed, homogenous atrophy of the retinal pigment epithelium and choriocapillaris in the macula, with surrounding yellow flecks and temporal optic nerve pallor. The phenotypic spectrum included a pattern dystrophy-like appearance, diffuse geographic atrophy, and extensive fundus flecks. Genotyping revealed that the two families were linked to chromosome 6q14 and shared a common haplotype spanning 21 cM between D6S430 and D6S300. The two families were subsequently shown by genealogic investigation to represent different branches of a common kindred.
CONCLUSIONS: Families with autosomal dominant Stargardt-like macular dystrophy linked to chromosome 6q14 share a common phenotype and in some cases can be distinguished from similar dystrophies by inheritance pattern and clinical features. The finding that these two families shared a common ancestor suggests the existence of a founder effect. Characterization of the gene for autosomal dominant Stargardt-like macular dystrophy may enable better understanding of this condition and elucidation of its potential role in other forms of macular degeneration.

Entities:  

Mesh:

Year:  1999        PMID: 10218695     DOI: 10.1016/s0002-9394(98)00331-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  17 in total

Review 1.  Genome editing revolutionize the creation of genetically modified pigs for modeling human diseases.

Authors:  Jing Yao; Jiaojiao Huang; Jianguo Zhao
Journal:  Hum Genet       Date:  2016-07-18       Impact factor: 4.132

Review 2.  Retinal very long-chain PUFAs: new insights from studies on ELOVL4 protein.

Authors:  Martin-Paul Agbaga; Md Nawajes A Mandal; Robert E Anderson
Journal:  J Lipid Res       Date:  2010-03-18       Impact factor: 5.922

Review 3.  Molecular genetics of macular degeneration.

Authors:  M A Musarella
Journal:  Doc Ophthalmol       Date:  2001-05       Impact factor: 2.379

Review 4.  Genotype-phenotype correlations and differential diagnosis in autosomal dominant macular disease.

Authors:  A Iannaccone
Journal:  Doc Ophthalmol       Date:  2001-05       Impact factor: 2.379

5.  Differential composition of DHA and very-long-chain PUFAs in rod and cone photoreceptors.

Authors:  Martin-Paul Agbaga; Dana K Merriman; Richard S Brush; Todd A Lydic; Shannon M Conley; Muna I Naash; Shelley Jackson; Amina S Woods; Gavin E Reid; Julia V Busik; Robert E Anderson
Journal:  J Lipid Res       Date:  2018-07-09       Impact factor: 5.922

Review 6.  Genetically modified pigs for biomedical research.

Authors:  Yonglun Luo; Lin Lin; Lars Bolund; Thomas G Jensen; Charlotte Brandt Sørensen
Journal:  J Inherit Metab Dis       Date:  2012-03-28       Impact factor: 4.982

7.  Hetero-oligomeric interactions of an ELOVL4 mutant protein: implications in the molecular mechanism of Stargardt-3 macular dystrophy.

Authors:  Ayaka Okuda; Tatsuro Naganuma; Yusuke Ohno; Kensuke Abe; Maki Yamagata; Yasuyuki Igarashi; Akio Kihara
Journal:  Mol Vis       Date:  2010-11-18       Impact factor: 2.367

8.  Inner retina remodeling in a mouse model of stargardt-like macular dystrophy (STGD3).

Authors:  Sharee Kuny; Frédéric Gaillard; Silvina C Mema; Paul R Freund; Kang Zhang; Ian M Macdonald; Janet R Sparrow; Yves Sauvé
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-20       Impact factor: 4.799

Review 9.  Genetically modified pigs to model human diseases.

Authors:  Tatiana Flisikowska; Alexander Kind; Angelika Schnieke
Journal:  J Appl Genet       Date:  2014-02       Impact factor: 3.240

Review 10.  Genetics and molecular pathology of Stargardt-like macular degeneration.

Authors:  Vidyullatha Vasireddy; Paul Wong; Radha Ayyagari
Journal:  Prog Retin Eye Res       Date:  2010-01-21       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.